Equity Research » Carlsquare Corporate Finance

Investment case Modus Therapeutics: Significant potential with proven technology

7 Jul 2021

Read the full report here (ENG): Investment case Modus 7 July 2021 Drug candidate and areas of use Modus…

Analysis DanCann Pharma Q1 2021: Good news flow increases fair value

3 Jun 2021

Read the full report here: Update DanCann Pharma Q1 2021, 03 June 2021 DanCann presented investments…

Mrkt BUZZ Arctic Minerals: Record high copper price implies potential

20 May 2021

Read the commentary here: Mrkt BUZZ Arctic Minerals May 20 2021 During the last 30 days the copper price…

The next generation of biopsy instruments

27 Apr 2021

Read the full report here: Initial_Coverage_Neodynamics_2021_04_27 NeoDynamics is a MedTech company that…

Investment Case All for One Group: The SAP S4/HANA conversion to last until 2027

26 Apr 2021

Read the full report here. Carlsquare ER Investment_case_All for One Group 26 April 2021 We see great…

The market is resembling the 1999 rally- focus on SPAC and crypto

16 Feb 2021

In 1999, the stock market was driven by a bonanza in tech during the so-called Dot-com bubble. It was…

Investment Case Frequentis: Stable growth in high-security business

26 Jan 2021

Read the full report here: Investment case Frequentis 26 Jan 2021 Frequentis offer its clients market…

Analysis Kancera: Capital raised for phase II

17 Mar 2020

Kancera’s main project KAND567 has successfully completed its phase Ib study. The next step is a…

Analysis Cantargia: targeted share issue – a sign of strength

10 Mar 2020

In February 2020 Cantargia implemented a targeted new share issue of SEK 410 million, which enables the…

Analysis Adventure Box: Good potential at high risk

10 Mar 2020

Adventure Box continues to grow in number of visitors on their platform. Numbers regarding active users…

Analysis Amasten: Exciting corner in SSM

9 Mar 2020

Amasten profit in Q4 2019 included relative small property value gains, though the overall result…

Analysis Flowscape: International expansion

5 Mar 2020

Flowscape increase its sales with a growing client base, where recurring revenues gradually will move up…

Jessica Algner

Assistant

Telephone: +49 30 809 33 47-12

Polina Amini

Senior Associate

Telephone: +49 40 300 836-14

Markus Augustsson

Head of Equity Research

Telephone: +46 76 235 03 20

Agata Barsallo

Office Management & Accounting

Telephone: +44 20 8017 6020

Caroline Berglund

Head of Equity Sales

Telephone: +46 73 382 10 82

Anders Bo

Managing Partner

Telephone: +45 4199 8252

Ulf Boberg

Senior Advisor Life Sciences

Telephone: +46 73 312 44 90

Manfred Drax

Partner

Telephone: +49 89 255 49 53-15

Anders Elgemyr

Managing Partner

Telephone: +46 70 496 18 15

Sebastian Fischer

Director

Telephone: +49 89 255 49 53-12

Daniel Garlipp

Managing Partner

Telephone: +49 40 300 836-19

Philip Goldhahn

Vice President

Telephone: +49 40 300 836-21

Thorsten Grandt

Vice President

Telephone: +49 30 809 33 47-20

Johan Heigard

Vice President

Telephone: +46 70 246 99 88

Caroline Heintz

Senior Associate

Telephone: +46 707 40 68 58

Maurice Hinrichs

Associate

Telephone: +49 40 300 836-20

Arnold Holle

Managing Partner

Telephone: +44 20 80176020

Lars Johansen

IT&Telecom Expert

Elaine Kelly

Head of Marketing

Telephone: +49 40 300 836 18

Anna-Lena Kickbusch

Office Management & Accounting

Telephone: +49 40 300 836 10

Morten Kjærulff

Partner

Telephone: +45 2634 9031

Mischa Krause

Director

Telephone: +49 40 300 836-24

Steffen Leckert

Managing Partner

Telephone: +49 89 255 49 53 26

Malve Liebig

Senior Associate

Telephone: +49 89 255 49 53-18

Erik Lundberg

Partner

Telephone: +46 73 850 35 59

Eva Macha

Office Management & PA to Michael Moritz

Telephone: +49 30 809 33 47-10

Mandy May

Head of Operations

Telephone: +49 30 809 33 47 16

Mirja Meyer

Office Management & Accounting

Telephone: +49 40 300 836 10

Mark Miller

Managing Partner

Telephone: +49 40 300 836-11

LinkedIn XING

Michael Moritz

Managing Partner

Telephone: +49 30 809 33 47-13

Bertil Nilsson

Senior Equity Analyst

Telephone: +46 70 434 90 03

Flemming C. Pedersen

Managing Partner

Telephone: +45 4199 8251

Richard Ramanius

Associate Equity Analyst

Telephone: +46 73 539 66 99

Anika Schaefer

Office Management & HR

Telephone: +49 89 255 495 310

Alexander Schleppegrel

Associate

Telephone: +45 2621 0543

Nico Schmidt-Weidemann

Partner

Telephone: +49 89 255 49 53-17

Caspar Graf Stauffenberg

Managing Partner

Telephone: +49 89 255 49 53-11

Gregor Steins

Associate

Telephone: +49 40 300 836-15

Jon Tingling

Senior Associate

Telephone: +44 77 1347-8286

Sybille de Vegvar

Business Development & Marketing

Telephone: +44 20 8017 6017

Oskar Wollert

Vice President

Telephone: +46 761 71 11 60

Nils Zettelmeyer

Director

Telephone: +49 30 809 33 47-25

Andreas Zetzsche

Partner

Telephone: +49 30 809 3347 33

Gerrit Zwarg

Senior Associate

Telephone: +49 40 300 836-28

Investment case Modus Therapeutics: Significant potential with proven technology

Analysis DanCann Pharma Q1 2021: Good news flow increases fair value

Mrkt BUZZ Arctic Minerals: Record high copper price implies potential

The next generation of biopsy instruments

Investment Case All for One Group: The SAP S4/HANA conversion to last until 2027

The market is resembling the 1999 rally- focus on SPAC and crypto

Investment Case Frequentis: Stable growth in high-security business

Analysis Kancera: Capital raised for phase II

Analysis Cantargia: targeted share issue – a sign of strength

Analysis Adventure Box: Good potential at high risk

Analysis Amasten: Exciting corner in SSM

Analysis Flowscape: International expansion

Berlin

Copenhagen

Hamburg

London

Munich

Stockholm

Team